Eficacia y tolerancia de la atorvastatina en el tratamiento de la dislipemia secundaria a tratamiento antirretroviral

Soler, Anna; Deig, Elisabet; Guil, Josep; Rodríguez-Martín, Marisa; Guelar, Ana; Pedrol, Enric.
Med. clín (Ed. impr.) ; 127(7): 250-252, jul. 2006. tab
Artículo en Es | IBECS (España) | ID: ibc-047154

Documentos relacionados

  1. The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
  2. Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.
  3. Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment.
  4. Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.
  5. An Insight into Antihyperlipidemic Effects of Polysaccharides from Natural Resources.
  6. Early Initiation of Antiretroviral Therapy Preserves the Metabolic Function of CD4+ T Cells in Subtype C Human Immunodeficiency Virus 1 Infection.
  7. Degradants of Tenofovir Disoproxil Fumarate Under Forced Yet Mild Thermal Stress: Isolation, Comprehensive Structural Elucidation, and Mechanism.
  8. Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia.
  9. The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV Infection.
  10. Changes in health and sleep quality after anti-retroviral treatment modification in Japanese people living with HIV.